Ashland Board appoints Ashish K. Kulkarni as new director
08 Mayo 2024 - 4:01PM
Ashland Inc. (NYSE: ASH) is announcing the appointment of Ashish K.
Kulkarni to its Board of Directors. Kulkarni is the CEO of Kebotix,
a startup company focused on commercializing artificial
intelligence methods into new material commercialization. He is the
former executive vice president and chief innovation officer, GAF,
former chief technology and innovation officer, Avantor and former
chief technology and innovation officer, Celanese Corporation. He
will serve on the Board's Environmental, Health, Safety and
Quality, and Compensation Committees, effective May 6,
2024. Prior to Celanese, Kulkarni held leadership
positions at United Technologies Corporation, American Standard and
General Electric.
With the addition of Kulkarni and in
anticipation of potential director retirements under the Board’s
retirement and resignation policy, Ashland increases the size of
the Board to 11 members.
Kulkarni is a highly experienced global
technology and innovation leader in premier companies across
diverse industries. He excels at building cultures and ecosystems
of innovation to accelerate the delivery of breakthrough products
and services that increase customer loyalty, market share, revenue
growth, profitability, and return on investment (ROI).
“I am pleased to welcome Ashish as a new
director to the Ashland Board,” said Guillermo Novo, chair and
chief executive officer, Ashland. “As we continue to execute our
strategy to shape and grow our portfolio, Ashish will provide
unique perspectives about advancing and accelerating scalable
growth.”
To learn more, visit investor.ashland.com
About Ashland
Ashland Inc. (NYSE: ASH) is a global additives and specialty
ingredients company with a conscious and proactive mindset for
environment, social and governance (ESG). The company serves
customers in a wide range of consumer and industrial markets,
including architectural coatings, construction, energy, food and
beverage, nutraceuticals, personal care and pharmaceutical.
Approximately 3,800 passionate, tenacious solvers – from renowned
scientists and research chemists to talented engineers and plant
operators – thrive on developing practical, innovative and elegant
solutions to complex problems for customers in more than 100
countries. Visit ashland.com and ashland.com/ESG to learn
more.
Forward-Looking Statements
This news release contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended and Section 21E of the Securities Exchange Act
of 1934, as amended. Ashland may from time to time make
forward-looking statements in its annual reports, quarterly reports
and other filings with the SEC, news releases and other written and
oral communications. These forward-looking statements are based on
Ashland’s expectations and assumptions, as of the date such
statements are made. These statements include but may not be
limited to, Ashland’s current expectations or beliefs concerning,
among other things, its future Board size. By their nature,
forward-looking statements involve risks and uncertainties because
they relate to events and depend on circumstances that may or may
not occur in the future. These risks and uncertainties affecting
Ashland are described in Ashland’s most recent Form 10-K (including
Item 1A Risk Factors) filed with the SEC, which is available on
Ashland’s website at http://investor.ashland.com or on the SEC’s
website at http://www.sec.gov. Various risks and uncertainties may
cause actual results to differ materially from those stated,
projected or implied by any forward-looking statements. Ashland
believes its expectations and assumptions are reasonable, but there
can be no assurance that the expectations reflected herein will be
achieved. Unless legally required, Ashland undertakes no obligation
to update any forward-looking statements made in this news release
whether as a result of new information, future events or
otherwise.
™ Trademark, Ashland or its subsidiaries,
registered in various countries.
FOR FURTHER INFORMATION:
Investor Relations: |
Media Relations: |
William Whitaker |
Carolmarie C. Brown |
+1 (614) 790-2095 |
+1 (302) 995-3158 |
wcwhitaker@ashland.com |
ccbrown@ashland.com |
- Ashland_announces_new_board_member_REV_FNL_20240508
Ashland (NYSE:ASH)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Ashland (NYSE:ASH)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025